title: Vitamin C activity of dehydroascorbic acid in humans--association between changes in the blood vitamin C concentration or urinary excretion after oral loading.
abstract: We performed oral loading of AsA or DAsA (1 mmol) in subjects who had consumed a diet low in vitamin C (C) (C< or =5 mg/d) for 3 d before loading, and measured urinary and blood vitamin C. Since the crossover method was used, the same experiment was repeated after an interval of about 1 mo in each subject. The results of the experiment including a total of 17 subjects for 2005 and 2006, were as follows. (1) There were marked individual differences in urinary C excretion. (2) The C level in 24-h urine after C loading did not differ between the two orally administered C forms (AsA and DAsA). (3) C excretion between 0 and 3 h after C loading was significantly higher (p<0.05) for the DAsA group, while those between 3 and 6, 6 and 9, 9 and 12, and 12 and 24 h after C loading were significantly higher (p<0.05 or p<0.01) for the AsA group. (4) The blood C concentration and the increase in C 1 h after C loading were significantly higher (p<0.05 and p<0.01, respectively) in the DAsA than in the AsA group. (5) Evaluation of the association between C metabolism and the single nucleotide polymorphisms of glutathione S-transferase P (GSTP) 1-1 showed a lower urinary C excretion and a significantly lower C level in 24-h urine (p<0.05) after AsA loading, and a significantly lower urinary C excretion between 0 and 3 h after DAsA loading (p<0.05) for the GA heterozygotes than for the AA homozygotes. Considering the activity of C as DAsA in humans, based on urinary and blood C levels after a single loading of C, the utilization of DAsA is equivalent to that of AsA, although the metabolic turnover time is different. The involvement of polymorphisms in the xenobiotic metabolizing enzyme, GSTP1-1, in C metabolism, particularly urinary C excretion, was also clarified. This demonstrates the necessity of considering gene polymorphisms in determining individual C requirements. An abstract of this paper was reported by the Vitamin C Research Committee (Ochanomizu University) in 2007.
authors.affiliation: Kagawa Nutrition University, 3-9-21 Chiyoda, Sakado, Saitama 350-0288, Japan. tsuji.m@eiyo.ac.jp
authors.forename: Masaru
authors.initials: M
authors.lastname: Tsujimura
authors.forename: Shizu
authors.initials: S
authors.lastname: Higasa
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Nakayama
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Yanagisawa
authors.forename: Sadahiko
authors.initials: S
authors.lastname: Iwamoto
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Kagawa
mesh_terms: D000284:Administration, Oral; D001205:Ascorbic Acid / Q000097:blood* / Q000652:urine*; D018592:Cross-Over Studies; D003683:Dehydroascorbic Acid / Q000008:administration & dosage / Q000097:blood / Q000652:urine; D005260:Female; D006801:Humans; D014815:Vitamins / Q000008:administration & dosage / Q000097:blood / Q000652:urine; D055815:Young Adult
chemical_list: D014815:Vitamins; D001205:Ascorbic Acid; D003683:Dehydroascorbic Acid